Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
This advanced formula combines Glutathione with Vitamins C & E, NAC, Alpha Lipoic Acid, Zinc, and Selenium to help support the body's natural antioxidant defenses
Specific volumes (5 ml) of aliquots were removed at predetermined time intervals (0.5, 1, 2, 4, 6, 8, 12, and 24 h)
It helps create that smooth, creamy feel and makes sure other ingredients can penetrate your skin instead of just sitting on top